Gregory Lizee

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Chantal Saberian

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Dinler Antunes

Assistant Professor of Computational Biology

University of Houston

UNITED STATES

View details

Yared Hailemichael

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Koichi Kobayashi

Professor

Hokkaido University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Lizee

Research Interests

Explore related searches

Contact this professor

Articles (10)

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer.

Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations.

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.

Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches.

Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches

IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.

NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy.

Markov state modeling reveals alternative unbinding pathways for peptide-MHC complexes.

Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.

Collaborators (4)

Chantal Saberian

Dinler Antunes

Yared Hailemichael

Koichi Kobayashi

Make your next move.